|
General Information
|
|
|
Product
|
PrLZ / TPD52 Antibody Antigenic Blocking Peptide
|
|
Description
|
Antigenic Blocking Peptide Prostate leucine zipper isoform 5 Antibody Mid-Region
|
|
Verified Applications
|
Immunocompeition, Immunodepletion
|
|
Peptide Description
|
Synthetic Peptide
|
|
Accession #
|
NCBI: NP_001020423.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
Mid-Region
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
1:500-1:1,000
|
|
Protein
|
|
Uniprot #
|
P55327
|
|
Molecular Function
|
calcium ion binding, protein heterodimerization activity, protein homodimerization activity
|
|
Subcellular Location
|
cytoplasm, perinuclear region of cytoplasm, endoplasmic reticulum
|
|
Expression
|
Isoform 2 is expressed in colon, breast, prostate, pancreas and kidney tumor cell lines. Isoform 2 is expressed at high levels in kidney, prostate, brain, small intestine and pancreas, at moderate levels in placenta and colon, at low levels in lung, liver
|
|
Structure
|
Forms a homodimer or heterodimer with other members of the family. All isoforms interact with several 14-3-3 proteins.
|
|
Alternative Nomenclature
|
D52 antibody
Human 19.8 kDa protein mRNA, complete cds antibody
N8L antibody
PC 1 antibody
PC1/MRPS28 fusion protein antibody
PrLZ antibody
Prostate and colon associated protein antibody
Prostate leucine zipper antibody
Protein N8 antibody
TPD52 antibody
Tumor protein D52 antibody
|
|
|
|
Prlz / TPD52 Antibody
Prlz / TPD52 Antibody FITC
Prlz / TPD52 Antibody BIOTIN
Prlz / TPD52 Positive Control
